Blockade of PAF receptors controls interleukin-8 production by regulating the activation of neutrophil CD11/CD18
- PMID: 11672576
- DOI: 10.1016/s0014-2999(01)01141-4
Blockade of PAF receptors controls interleukin-8 production by regulating the activation of neutrophil CD11/CD18
Abstract
The production of interleukin-8 by neutrophils in response to particulate stimuli may play a role in the recruitment and activation of further neutrophils in an inflammatory reaction. Here, we have evaluated the sequence of early events leading to interleukin-8 production by phagocytosing neutrophils. Kinetic experiments showed that the phagocytosis of zymosan particles by human neutrophils was rapid in onset. In contrast, interleukin-8 production was more protracted and only detectable 6 h later. Nevertheless, inhibition of phagocytosis with cytochalasins B or D suppressed the late interleukin-8 production. Activation of neutrophils with zymosan failed to enhance CD11/CD18 expression on the neutrophil surface but led to an increase in the expression of an activation-dependent epitope on CD11/CD18. Pretreatment with the platelet-activating factor (PAF) receptor antagonist, UK-74505 (4-(2-chlorophenyl)-1,4-dihydro-3-ethoxycarbonyl-6-methyl-2-[4-(2-methylimidazol[4,5-c]pyrid-1-yl)phenyl]-5-[N-(2-pyridyl)carbamoyl]pyridine), significantly blocked the increase in the expression of the activation epitope, resulting in inhibition of the phagocytosis of zymosan and interleukin-8 production. In conclusion, the activation of neutrophils with zymosan leads to the activation of PAF receptors and this is followed by activation of CD11/CD18, phagocytosis of zymosan particles and subsequent interleukin-8 release.
Similar articles
-
Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.Br J Pharmacol. 1994 Oct;113(2):513-21. doi: 10.1111/j.1476-5381.1994.tb17019.x. Br J Pharmacol. 1994. PMID: 7834203 Free PMC article.
-
Zymosan-induced IL-8 release from human neutrophils involves activation via the CD11b/CD18 receptor and endogenous platelet-activating factor as an autocrine modulator.J Immunol. 1994 Jun 1;152(11):5411-9. J Immunol. 1994. PMID: 7514637
-
CD63 associates with CD11/CD18 in large detergent-resistant complexes after translocation to the cell surface in human neutrophils.FEBS Lett. 2000 Mar 3;469(1):52-6. doi: 10.1016/s0014-5793(00)01240-0. FEBS Lett. 2000. PMID: 10708755
-
Granulocyte dysplasia and dysfunction, and CD11/CD18 defects in myelodysplastic syndromes.Leuk Lymphoma. 1996 Oct;23(3-4):267-75. doi: 10.3109/10428199609054829. Leuk Lymphoma. 1996. PMID: 9031107 Review.
-
Interleukin-15 and its impact on neutrophil function.Curr Opin Hematol. 2000 May;7(3):174-7. doi: 10.1097/00062752-200005000-00008. Curr Opin Hematol. 2000. PMID: 10786655 Review.
Cited by
-
Platelet-activating factor receptor deficiency delays elimination of adult worms but reduces fecundity in Strongyloides venezuelensis-infected mice.Infect Immun. 2004 Feb;72(2):1135-42. doi: 10.1128/IAI.72.2.1135-1142.2004. Infect Immun. 2004. PMID: 14742561 Free PMC article.
-
Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria.Br J Pharmacol. 2002 Nov;137(5):621-8. doi: 10.1038/sj.bjp.0704918. Br J Pharmacol. 2002. PMID: 12381675 Free PMC article.
-
Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice.Br J Pharmacol. 2002 Mar;135(5):1213-8. doi: 10.1038/sj.bjp.0704570. Br J Pharmacol. 2002. PMID: 11877329 Free PMC article.
-
Modulation of neutrophil function by the tripeptide feG.BMC Immunol. 2003 Mar 4;4:3. doi: 10.1186/1471-2172-4-3. Epub 2003 Mar 4. BMC Immunol. 2003. PMID: 12659660 Free PMC article.
-
Role of platelet-activating factor in the pathogenesis of acute pancreatitis.World J Gastroenterol. 2006 Jan 28;12(4):539-45. doi: 10.3748/wjg.v12.i4.539. World J Gastroenterol. 2006. PMID: 16489665 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources